A multi-center, randomized, open label, controlled study to compare the Sustained Virological Response during treatment with Neoral or tacrolimus in maintenance liver transplant recipients treated with pegylated interferon and ribavirin for recurrent Hepatitis C

Trial Profile

A multi-center, randomized, open label, controlled study to compare the Sustained Virological Response during treatment with Neoral or tacrolimus in maintenance liver transplant recipients treated with pegylated interferon and ribavirin for recurrent Hepatitis C

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 May 2016

At a glance

  • Drugs Ciclosporin (Primary) ; Peginterferon; Ribavirin; Tacrolimus
  • Indications Hepatitis C; Liver transplant rejection
  • Focus Therapeutic Use
  • Acronyms SUSTAIN
  • Sponsors Novartis; Novartis Pharmaceuticals
  • Most Recent Events

    • 01 May 2016 This study is suspended in Italy as per European Clinical Trials Database record.
    • 04 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top